US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn

Fisher & Paykel could pass on potential tariff costs to customers, but those options will be limited by its market postition, Craigs analysts say. (Image: Fisher & Paykel Healthcare)

Rebecca Stevenson

Tue, 28 Jan 2025

US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A research note by Craigs Investment Partners considered three potential tariff scenarios from the new US government under the leadership of President Donald Trump. About 40% of New Zealand Exchange-listed (NX) Fisher & Paykel Healthcare’s sales are in the US, or about 75% of its revenue. Trump has threatened to levy tariffs against imports from countries such as Mexico, Canada and China....

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.